Thyrosafe Tablet
NDC Package 50633-910-20

11-digit billing NDC: 50633091020

Package Information

Thyrosafe (potassium iodide) tablets is dIRECTIONS FOR USEUse only as directed by public officials if a nuclear radiation emergency happens. This formulation utilizes a tablet delivery system. Marketed by Btg International Inc., this product is identified by NDC 50633-910 and is authorized under FDA application ANDA076350.

Identification & Billing

NDC Package Code
50633-910-20
Package Description
160 BOX in 1 CARTON / 20 BLISTER PACK in 1 BOX / 1 TABLET in 1 BLISTER PACK
Product Code
11-Digit Billing Format
50633091020
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Thyrosafe
Non-Proprietary Name
Potassium Iodide
Substance Name
Potassium Iodide
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
DIRECTIONS FOR USEUse only as directed by public officials if a nuclear radiation emergency happens.

Regulatory & Marketing

Labeler Name
Btg International Inc.
Product Type
Human Otc Drug
FDA Application #
ANDA076350
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-30-2002
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50633-910-20 identifies a specific commercial package of 160 box in 1 carton / 20 blister pack in 1 box / 1 tablet in 1 blister pack of Thyrosafe, a human over the counter drug labeled by Btg International Inc.. This tablet is formulated for oral use and contains potassium iodide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Btg International Inc. on September 30, 2002. The current certification is valid through December 31, 2027.

How is this Btg International Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50633091020. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50633-910-20
11-Digit CMS (5-4-2)
50633-0910-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.